NCT03934372
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03934372 |
| Title | Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Incyte Biosciences International Sarl |
| Indications | |
| Therapies | |
| Age Groups: | child |
| Covered Countries | SWE | NLD | ITA | GBR | FRA | ESP | DNK | DEU | BEL |
CKB BOOST